Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Mycophenolate Mofetil Useful for Scleroderma-Associated Interstitial Lung Disease
Link ID 3623
Title Mycophenolate Mofetil Useful for Scleroderma-Associated Interstitial Lung Disease
Url http://www.medscape.com/viewarticle/570790?src=rss
Description Treatment with mycophenolate mofetil (MMF) improves vital capacity in patients with scleroderma-associated interstitial lung disease (ILD), according to a small study reported in the February issue of Chest. Reuters Health Information
Category Articles > Dermatology
Keywords
Date Feb 29, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Dermatology
1. The Use of Elastocompressive Therapy in a Patient With Acroangiodermatitis of the Lower Limb
  A case of a 63-year-old man with acroangiodermatitis of the lower limbs and chronic venous insufficiency.
Wounds
Category:   Articles > Dermatology


2. Occupational Injuries Very Common in Surgeons
  A survey of more than 350 plastic surgeons indicates that occupational injuries, especially muscle strains, are the norm, not the exception with this profession, according to study findings to be presented next month at the American Society of Plastic Surgery meeting in Chicago. Reuters Health Information
Category:   Articles > Dermatology


3. Mycophenolate Mofetil Useful for Scleroderma-Associated Interstitial Lung Disease
  Treatment with mycophenolate mofetil (MMF) improves vital capacity in patients with scleroderma-associated interstitial lung disease (ILD), according to a small study reported in the February issue of Chest. Reuters Health Information
Category:   Articles > Dermatology


4. Quinapril Fails to Prevent Vascular Damage in Scleroderma
  The long-acting angiotensin-converting enzyme (ACE) inhibitor quinapril does not appear to prevent upper limb digital ulcers or other vascular manifestations in patients with limited cutaneous systemic sclerosis (lcSSc), according to UK researchers. Reuters Health Information
Category:   Articles > Dermatology


5. Persistent Cutaneous Hyperpigmentation After Tyrosine Kinase Inhibition With Imatinib for GIST
  Imatinib mesylate, a tyrosine kinase inhibitor, is an important part of the therapeutic armamentarium used in chronic myelogenous leukemia and gastrointestinal stromal tumors. Dermatological toxicities occur with the clinical use of this drug range from various acute rashes to Steven-Johnson syndrome. Hyperpigmentation of the skin is a less frequent side effect.
Dermatology Online Journal
Category:   Articles > Dermatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS